Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700503 · ClinicalTrials.gov registry record · NA
Finding the Patient's Voice Diabetes Prevention Programs
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT02700503: Completed NA study, sponsored by Indiana University.
NCT02700503 is a NA study that has completed, run by Indiana University. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02700503, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
This study uses patient engagement to develop a diabetes prevention program focused on adolescents and families.
Interventions
- BEHAVIORAL Encourage 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-06 |
| Phase | NA |
What the finished NCT02700503 record still lists
NCT02700503 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Encourage 2.0 is the first listed.
NCT02700503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02700503 about?
NCT02700503 is a clinical study titled "Finding the Patient's Voice Diabetes Prevention Programs". This study uses patient engagement to develop a diabetes prevention program focused on adolescents and families.
What is the current status of trial NCT02700503?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2015-11. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02700503?
The interventions under investigation include: Encourage 2.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02700503?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02700503's enrollment target sits among peer trials
146 704th of 2000 higher than 1,296 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia